Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Synthesis of novel carbazole based styryl: rational approach for photophysical properties and TD-DFT.

Journal of fluorescence

Sekar N, Umape PG, Kothavale S, Deshmukh M.
PMID: 25117827
J Fluoresc. 2014 Sep;24(5):1457-72. doi: 10.1007/s10895-014-1429-5. Epub 2014 Aug 13.

The synthesis and solvatochromic behavior of four novel carbazole based fluorescent styryl dyes were explained. In chlorinated solvents such as DCM and chloroform, these dyes show bathochromic shift in their absorption as well as emission. The styryl dyes 6b...

Cite
Sekar N, Umape PG, Kothavale S, et al. Synthesis of novel carbazole based styryl: rational approach for photophysical properties and TD-DFT. J Fluoresc. 2014;24(5):1457-72doi: 10.1007/s10895-014-1429-5.
Sekar, N., Umape, P. G., Kothavale, S., & Deshmukh, M. (2014). Synthesis of novel carbazole based styryl: rational approach for photophysical properties and TD-DFT. Journal of fluorescence, 24(5), 1457-72. https://doi.org/10.1007/s10895-014-1429-5
Sekar, Nagaiyan, et al. "Synthesis of novel carbazole based styryl: rational approach for photophysical properties and TD-DFT." Journal of fluorescence vol. 24,5 (2014): 1457-72. doi: https://doi.org/10.1007/s10895-014-1429-5
Sekar N, Umape PG, Kothavale S, Deshmukh M. Synthesis of novel carbazole based styryl: rational approach for photophysical properties and TD-DFT. J Fluoresc. 2014 Sep;24(5):1457-72. doi: 10.1007/s10895-014-1429-5. Epub 2014 Aug 13. PMID: 25117827.
Copy Download .nbib Format: NLM
Recognition of leguminous hosts by a promiscuous Rhizobium strain.

Applied and environmental microbiology

Shantharam S, Wong PP.
PMID: 16345975
Appl Environ Microbiol. 1982 Mar;43(3):677-85. doi: 10.1128/aem.43.3.677-685.1982.

The lima bean (Phaseolus lunatus L.) and the pole bean (Phaseolus vulgaris L.) are nodulated by rhizobia of two different cross-inoculation groups. Rhizobium sp. 127E15, a cowpea-type Rhizobium, can induce effective nodules on the lima bean and partially effective...

Cite
Shantharam S, Wong PP. Recognition of leguminous hosts by a promiscuous Rhizobium strain. Appl Environ Microbiol. 1982;43(3):677-85doi: 10.1128/aem.43.3.677-685.1982.
Shantharam, S., & Wong, P. P. (1982). Recognition of leguminous hosts by a promiscuous Rhizobium strain. Applied and environmental microbiology, 43(3), 677-85. https://doi.org/10.1128/aem.43.3.677-685.1982
Shantharam, S, and Wong, P P. "Recognition of leguminous hosts by a promiscuous Rhizobium strain." Applied and environmental microbiology vol. 43,3 (1982): 677-85. doi: https://doi.org/10.1128/aem.43.3.677-685.1982
Shantharam S, Wong PP. Recognition of leguminous hosts by a promiscuous Rhizobium strain. Appl Environ Microbiol. 1982 Mar;43(3):677-85. doi: 10.1128/aem.43.3.677-685.1982. PMID: 16345975; PMCID: PMC241894.
Copy Download .nbib Format: NLM
Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats.

Oriental pharmacy and experimental medicine

Pandhare RB, Sangameswaran B, Mohite PB, Khanage SG.
PMID: 22924034
Orient Pharm Exp Med. 2012 Sep;12(3):197-203. doi: 10.1007/s13596-012-0074-2. Epub 2012 May 24.

In India, Adenanthera pavonina is traditionally used in the treatment of diabetes mellitus and lipid disorders. In the present study, the antihyperglycaemic and lipid lowering effect of Adenanthera pavonina seed aqueous extract (APSAE) was evaluated using streptozotocin induced diabetes...

Cite
Pandhare RB, Sangameswaran B, Mohite PB, et al. Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats. Orient Pharm Exp Med. 2012;12(3):197-203doi: 10.1007/s13596-012-0074-2.
Pandhare, R. B., Sangameswaran, B., Mohite, P. B., & Khanage, S. G. (2012). Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats. Oriental pharmacy and experimental medicine, 12(3), 197-203. https://doi.org/10.1007/s13596-012-0074-2
Pandhare, Ramdas B, et al. "Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats." Oriental pharmacy and experimental medicine vol. 12,3 (2012): 197-203. doi: https://doi.org/10.1007/s13596-012-0074-2
Pandhare RB, Sangameswaran B, Mohite PB, Khanage SG. Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats. Orient Pharm Exp Med. 2012 Sep;12(3):197-203. doi: 10.1007/s13596-012-0074-2. Epub 2012 May 24. PMID: 22924034; PMCID: PMC3423570.
Copy Download .nbib Format: NLM
Reply to S. Boutayeb et al.

JCO oncology practice

Lou E, Beg MS, Bergsland E, Eng C, Khorana AA, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY.
PMID: 32574129
JCO Oncol Pract. 2020 Aug;16(8):525. doi: 10.1200/OP.20.00394. Epub 2020 Jun 23.

No abstract available.

Cite
Lou E, Beg MS, Bergsland E, et al. Reply to S. Boutayeb et al. JCO Oncol Pract. 2020;16(8):525doi: 10.1200/OP.20.00394.
Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., Lubner, S., Saltz, L., Shankaran, V., & Zafar, S. Y. (2020). Reply to S. Boutayeb et al. JCO oncology practice, 16(8), 525. https://doi.org/10.1200/OP.20.00394
Lou, Emil, et al. "Reply to S. Boutayeb et al." JCO oncology practice vol. 16,8 (2020): 525. doi: https://doi.org/10.1200/OP.20.00394
Lou E, Beg MS, Bergsland E, Eng C, Khorana AA, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY. Reply to S. Boutayeb et al. JCO Oncol Pract. 2020 Aug;16(8):525. doi: 10.1200/OP.20.00394. Epub 2020 Jun 23. PMID: 32574129.
Copy Download .nbib Format: NLM
Doing More with More: How "Early" Evidence Can Inform Public Policies.

Public administration review

Barbero C, Gilchrist S, Shantharam S, Fulmer E, Schooley MW.
PMID: 32684642
Public Adm Rev. 2017 Aug;77(5):646-649. doi: 10.1111/puar.12831.

No abstract available.

Cite
Barbero C, Gilchrist S, Shantharam S, et al. Doing More with More: How "Early" Evidence Can Inform Public Policies. Public Adm Rev. 2017;77(5):646-649doi: 10.1111/puar.12831.
Barbero, C., Gilchrist, S., Shantharam, S., Fulmer, E., & Schooley, M. W. (2017). Doing More with More: How "Early" Evidence Can Inform Public Policies. Public administration review, 77(5), 646-649. https://doi.org/10.1111/puar.12831
Barbero, Colleen, et al. "Doing More with More: How "Early" Evidence Can Inform Public Policies." Public administration review vol. 77,5 (2017): 646-649. doi: https://doi.org/10.1111/puar.12831
Barbero C, Gilchrist S, Shantharam S, Fulmer E, Schooley MW. Doing More with More: How "Early" Evidence Can Inform Public Policies. Public Adm Rev. 2017 Aug;77(5):646-649. doi: 10.1111/puar.12831. PMID: 32684642; PMCID: PMC7367649.
Copy Download .nbib Format: NLM
Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Shankaran V, Li L, Fedorenko C, Sanchez H, Du Y, Khor S, Kreizenbeck K, Ramsey S.
PMID: 34995125
J Clin Oncol. 2022 Jan 07;JCO2101636. doi: 10.1200/JCO.21.01636. Epub 2022 Jan 07.

PURPOSE: Although financial toxicity is a growing cancer survivorship issue, no studies have used credit data to estimate the relative risk of financial hardship in patients with cancer versus individuals without cancer. We conducted a population-based retrospective matched cohort...

Cite
Shankaran V, Li L, Fedorenko C, et al. Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records. J Clin Oncol. 2022;JCO2101636doi: 10.1200/JCO.21.01636.
Shankaran, V., Li, L., Fedorenko, C., Sanchez, H., Du, Y., Khor, S., Kreizenbeck, K., & Ramsey, S. (2022). Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2101636. https://doi.org/10.1200/JCO.21.01636
Shankaran, Veena, et al. "Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2022): JCO2101636. doi: https://doi.org/10.1200/JCO.21.01636
Shankaran V, Li L, Fedorenko C, Sanchez H, Du Y, Khor S, Kreizenbeck K, Ramsey S. Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records. J Clin Oncol. 2022 Jan 07;JCO2101636. doi: 10.1200/JCO.21.01636. Epub 2022 Jan 07. PMID: 34995125.
Copy Download .nbib Format: NLM
Genomic analysis of patients in a South Indian Community with autosomal dominant cortical tremor, myoclonus and epilepsy suggests a founder repeat expansion mutation in the .

Brain communications

Mahadevan R, Bhoyar RC, Viswanathan N, Rajagopal RE, Essaki B, Suroliya V, Chelladurai R, Sankaralingam S, Shanmugam G, Vayanakkan S, Shamim U, Mathur A, Jain A, Imran M, Faruq M, Scaria V, Sivasubbu S, Kalyanaraman S.
PMID: 33501421
Brain Commun. 2020 Dec 19;3(1):fcaa214. doi: 10.1093/braincomms/fcaa214. eCollection 2021.

Autosomal Dominant Cortical Tremor, Myoclonus and Epilepsy is a non-progressive disorder characterized by distal tremors. Autosomal Dominant Cortical Tremor, Myoclonus and Epilepsy has been reported globally with different genetic predispositions of autosomal dominant inheritance with a high degree of...

Cite
Mahadevan R, Bhoyar RC, Viswanathan N, et al. Genomic analysis of patients in a South Indian Community with autosomal dominant cortical tremor, myoclonus and epilepsy suggests a founder repeat expansion mutation in the . Brain Commun. 2020;3(1):fcaa214doi: 10.1093/braincomms/fcaa214.
Mahadevan, R., Bhoyar, R. C., Viswanathan, N., Rajagopal, R. E., Essaki, B., Suroliya, V., Chelladurai, R., Sankaralingam, S., Shanmugam, G., Vayanakkan, S., Shamim, U., Mathur, A., Jain, A., Imran, M., Faruq, M., Scaria, V., Sivasubbu, S., & Kalyanaraman, S. (2021). Genomic analysis of patients in a South Indian Community with autosomal dominant cortical tremor, myoclonus and epilepsy suggests a founder repeat expansion mutation in the . Brain communications, 3(1), fcaa214. https://doi.org/10.1093/braincomms/fcaa214
Mahadevan, Radha, et al. "Genomic analysis of patients in a South Indian Community with autosomal dominant cortical tremor, myoclonus and epilepsy suggests a founder repeat expansion mutation in the ." Brain communications vol. 3,1 (2021): fcaa214. doi: https://doi.org/10.1093/braincomms/fcaa214
Mahadevan R, Bhoyar RC, Viswanathan N, Rajagopal RE, Essaki B, Suroliya V, Chelladurai R, Sankaralingam S, Shanmugam G, Vayanakkan S, Shamim U, Mathur A, Jain A, Imran M, Faruq M, Scaria V, Sivasubbu S, Kalyanaraman S. Genomic analysis of patients in a South Indian Community with autosomal dominant cortical tremor, myoclonus and epilepsy suggests a founder repeat expansion mutation in the . Brain Commun. 2020 Dec 19;3(1):fcaa214. doi: 10.1093/braincomms/fcaa214. eCollection 2021. PMID: 33501421; PMCID: PMC7811760.
Copy Download .nbib Format: NLM
Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Ramsey SD, Shankaran V, Sullivan SD.
PMID: 31233352
J Clin Oncol. 2019 Dec 20;37(36):3472-3474. doi: 10.1200/JCO.18.02320. Epub 2019 Jun 24.

No abstract available.

Cite
Ramsey SD, Shankaran V, Sullivan SD. Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources. J Clin Oncol. 2019;37(36):3472-3474doi: 10.1200/JCO.18.02320.
Ramsey, S. D., Shankaran, V., & Sullivan, S. D. (2019). Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(36), 3472-3474. https://doi.org/10.1200/JCO.18.02320
Ramsey, Scott D, et al. "Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 37,36 (2019): 3472-3474. doi: https://doi.org/10.1200/JCO.18.02320
Ramsey SD, Shankaran V, Sullivan SD. Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources. J Clin Oncol. 2019 Dec 20;37(36):3472-3474. doi: 10.1200/JCO.18.02320. Epub 2019 Jun 24. PMID: 31233352.
Copy Download .nbib Format: NLM
Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care.

Seminars in hematology

Yezefski T, Schwemm A, Lentz M, Hone K, Shankaran V.
PMID: 30502845
Semin Hematol. 2018 Oct;55(4):185-188. doi: 10.1053/j.seminhematol.2017.07.004. Epub 2017 Sep 21.

High out-of-pocket (OOP) spending on cancer drugs is a known contributor to "financial toxicity" among cancer patients. Many predict that this problem will only worsen as patients continue to bear more responsibility for the cost of their medical care...

Cite
Yezefski T, Schwemm A, Lentz M, et al. Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care. Semin Hematol. 2017;55(4):185-188doi: 10.1053/j.seminhematol.2017.07.004.
Yezefski, T., Schwemm, A., Lentz, M., Hone, K., & Shankaran, V. (2018). Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care. Seminars in hematology, 55(4), 185-188. https://doi.org/10.1053/j.seminhematol.2017.07.004
Yezefski, Todd, et al. "Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care." Seminars in hematology vol. 55,4 (2018): 185-188. doi: https://doi.org/10.1053/j.seminhematol.2017.07.004
Yezefski T, Schwemm A, Lentz M, Hone K, Shankaran V. Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care. Semin Hematol. 2018 Oct;55(4):185-188. doi: 10.1053/j.seminhematol.2017.07.004. Epub 2017 Sep 21. PMID: 30502845.
Copy Download .nbib Format: NLM
Documentation and Reporting of Perinatal Deaths in Two Districts of Karnataka, India: A Situational Analysis.

Indian pediatrics

Kumar HNH, Baliga S, Kushtagi P, Kamath N, Rao SS.
PMID: 32533680
Indian Pediatr. 2020 Nov 15;57(11):1006-1009. Epub 2020 Jun 12.

OBJECTIVE: In Karnataka state, perinatal mortality rate is almost equal to infant mortality rate. This preliminary study was conducted in two districts of Karnataka to study potential problems to start of perinatal death audit.METHODS: Hospitals providing maternal and child...

Cite
Kumar HNH, Baliga S, Kushtagi P, et al. Documentation and Reporting of Perinatal Deaths in Two Districts of Karnataka, India: A Situational Analysis. Indian Pediatr. 2020;57(11):1006-1009
Kumar, H. N. H., Baliga, S., Kushtagi, P., Kamath, N., & Rao, S. S. (2020). Documentation and Reporting of Perinatal Deaths in Two Districts of Karnataka, India: A Situational Analysis. Indian pediatrics, 57(11), 1006-1009.
Kumar, H N Harsha, et al. "Documentation and Reporting of Perinatal Deaths in Two Districts of Karnataka, India: A Situational Analysis." Indian pediatrics vol. 57,11 (2020): 1006-1009.
Kumar HNH, Baliga S, Kushtagi P, Kamath N, Rao SS. Documentation and Reporting of Perinatal Deaths in Two Districts of Karnataka, India: A Situational Analysis. Indian Pediatr. 2020 Nov 15;57(11):1006-1009. Epub 2020 Jun 12. PMID: 32533680.
Copy Download .nbib Format: NLM
Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018.

Journal of hepatocellular carcinoma

Shankaran V, Chennupati S, Sanchez H, Sun Q, Li L, Fedorenko C, Aly A, Healey M, Seal B.
PMID: 34938673
J Hepatocell Carcinoma. 2021 Dec 14;8:1597-1606. doi: 10.2147/JHC.S328274. eCollection 2021.

INTRODUCTION: Though the treatment landscape for hepatocellular carcinoma (HCC) has evolved significantly with the refinement of liver-directed therapy techniques and the introduction of new drugs, few studies have investigated the impact of the changing treatment landscape on lifetime treatment...

Cite
Shankaran V, Chennupati S, Sanchez H, et al. Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018. J Hepatocell Carcinoma. 2021;8:1597-1606doi: 10.2147/JHC.S328274.
Shankaran, V., Chennupati, S., Sanchez, H., Sun, Q., Li, L., Fedorenko, C., Aly, A., Healey, M., & Seal, B. (2021). Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018. Journal of hepatocellular carcinoma, 81597-1606. https://doi.org/10.2147/JHC.S328274
Shankaran, Veena, et al. "Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018." Journal of hepatocellular carcinoma vol. 8 (2021): 1597-1606. doi: https://doi.org/10.2147/JHC.S328274
Shankaran V, Chennupati S, Sanchez H, Sun Q, Li L, Fedorenko C, Aly A, Healey M, Seal B. Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018. J Hepatocell Carcinoma. 2021 Dec 14;8:1597-1606. doi: 10.2147/JHC.S328274. eCollection 2021. PMID: 34938673; PMCID: PMC8685386.
Copy Download .nbib Format: NLM
Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes.

Journal, genetic engineering & biotechnology

Jain A, Bhoyar RC, Pandhare K, Mishra A, Sharma D, Imran M, Senthivel V, Divakar MK, Rophina M, Jolly B, Batra A, Sharma S, Siwach S, Jadhao AG, Palande NV, Jha GN, Ashrafi N, Mishra PK, A K V, Jain S, Dash D, Kumar NS, Vanlallawma A, Sarma RJ, Chhakchhuak L, Kalyanaraman S, Mahadevan R, Kandasamy S, B M P, Rajagopal RE, Ramya J E, Devi P N, Bajaj A, Gupta V, Mathew S, Goswami S, Mangla M, Prakash S, Joshi K, Meyakumla, S S, Gajjar D, Soraisham R, Yadav R, Devi YS, Gupta A, Mukerji M, Ramalingam S, B K B, Scaria V, Sivasubbu S.
PMID: 34905135
J Genet Eng Biotechnol. 2021 Dec 14;19(1):183. doi: 10.1186/s43141-021-00268-2.

BACKGROUND: Autoinflammatory disorders are the group of inherited inflammatory disorders caused due to the genetic defect in the genes that regulates innate immune systems. These have been clinically characterized based on the duration and occurrence of unprovoked fever, skin...

Cite
Jain A, Bhoyar RC, Pandhare K, et al. Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes. J Genet Eng Biotechnol. 2021;19(1):183doi: 10.1186/s43141-021-00268-2.
Jain, A., Bhoyar, R. C., Pandhare, K., Mishra, A., Sharma, D., Imran, M., Senthivel, V., Divakar, M. K., Rophina, M., Jolly, B., Batra, A., Sharma, S., Siwach, S., Jadhao, A. G., Palande, N. V., Jha, G. N., Ashrafi, N., Mishra, P. K., A K, V., Jain, S., Dash, D., Kumar, N. S., Vanlallawma, A., Sarma, R. J., Chhakchhuak, L., Kalyanaraman, S., Mahadevan, R., Kandasamy, S., B M, P., Rajagopal, R. E., Ramya J, E., Devi P, N., Bajaj, A., Gupta, V., Mathew, S., Goswami, S., Mangla, M., Prakash, S., Joshi, K., Meyakumla, S, S., Gajjar, D., Soraisham, R., Yadav, R., Devi, Y. S., Gupta, A., Mukerji, M., Ramalingam, S., B K, B., Scaria, V., & Sivasubbu, S. (2021). Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes. Journal, genetic engineering & biotechnology, 19(1), 183. https://doi.org/10.1186/s43141-021-00268-2
Jain, Abhinav, et al. "Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes." Journal, genetic engineering & biotechnology vol. 19,1 (2021): 183. doi: https://doi.org/10.1186/s43141-021-00268-2
Jain A, Bhoyar RC, Pandhare K, Mishra A, Sharma D, Imran M, Senthivel V, Divakar MK, Rophina M, Jolly B, Batra A, Sharma S, Siwach S, Jadhao AG, Palande NV, Jha GN, Ashrafi N, Mishra PK, A K V, Jain S, Dash D, Kumar NS, Vanlallawma A, Sarma RJ, Chhakchhuak L, Kalyanaraman S, Mahadevan R, Kandasamy S, B M P, Rajagopal RE, Ramya J E, Devi P N, Bajaj A, Gupta V, Mathew S, Goswami S, Mangla M, Prakash S, Joshi K, Meyakumla, S S, Gajjar D, Soraisham R, Yadav R, Devi YS, Gupta A, Mukerji M, Ramalingam S, B K B, Scaria V, Sivasubbu S. Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes. J Genet Eng Biotechnol. 2021 Dec 14;19(1):183. doi: 10.1186/s43141-021-00268-2. PMID: 34905135.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries